10.1046/j.1365-2826.2001.00705.x
1995, Biochim Biophys Acta, 1259, 125, 10.1016/0005-2760(95)00143-Z
10.1046/j.0022-3042.2001.00697.x
10.1089/152308603770310329
10.1016/0006-2952(95)02172-8
10.1046/j.1471-4159.2003.02087.x
10.1016/j.neulet.2004.05.001
10.1016/S0014-2999(97)85419-2
10.1016/j.nut.2003.09.018
1999, Stroke, 30, 1464, 10.1161/01.STR.30.7.1464
1985, Cent Nerv Syst Trauma, 2, 257, 10.1089/cns.1985.2.257
10.1046/j.0953-816x.2001.01623.x
10.1046/j.1460-9568.2003.02470.x
10.1016/S0014-5793(02)03481-6
10.1046/j.1471-4159.2003.01811.x
10.1016/S0166-2236(00)01659-3
1983, Br Med Bull, 39, 260, 10.1093/oxfordjournals.bmb.a071830
10.1046/j.1471-4159.2003.02118.x
10.1034/j.1600-0854.2003.00078.x
10.1016/S0014-2999(99)00011-4
10.1016/S0955-2863(96)00057-5
10.1016/j.neuron.2004.08.013
10.1002/(SICI)1098-1063(1998)8:3<299::AID-HIPO11>3.0.CO;2-W
10.1016/S0898-6568(02)00144-4
10.1517/13543776.14.7.937
1987, J Biol Chem, 262, 4402, 10.1016/S0021-9258(18)61362-6
10.1046/j.1601-5215.2003.00049.x
2000, J Pharmacol Exp Ther, 294, 793
de Wilde MC, Leenders I, Broersen LM, Kuipers AAM, van der Beek EM, and Kiliaan AJ (2003) The omega-3 fatty acid docosahexaenoic acid (DHA) inhibits the formation of beta amyloid in CHO7PA2 cells, in Society for Neuroscience 33rd Annual Meeting Abstracts; 2003 Nov 8-12; New Orleans, LA; Abstract nr 730.11.
10.1016/S0272-2712(02)00041-0
2003, J Neurosurg, 98, 867, 10.3171/jns.2003.98.4.0867
1999, Soc Neurosci Abs, 25, 2206
10.1128/JVI.74.10.4894-4897.2000
1986, Biochim Biophys Acta, 876, 639, 10.1016/0005-2760(86)90053-6
1982, Fertil Steril, 38, 735, 10.1016/S0015-0282(16)46703-8
1982, J Neurochem, 39, 1111, 10.1111/j.1471-4159.1982.tb11503.x
10.1097/00041433-199602000-00011
10.1016/S0006-8993(96)01450-3
10.1016/j.brainresrev.2004.03.002
Farooqui AA, Haun SE, and Horrocks LA (1994a) Ischemia and hypoxia, in Basic Neurochemistry (Siegel GJ, Agranoff BW, Albers RW, and Molinoff PB eds) pp 867-883, Raven Press, New York.
10.1016/0165-0173(91)90004-R
1994, Int Rev Neurobiol, 36, 267, 10.1016/S0074-7742(08)60306-2
10.1177/107385840100700308
2004, Agro Food Ind Hi-Tech, 15, 52
Farooqui AA and Horrocks LA (2004b) Plasmalogens, platelet activating factor, and other ether lipids, in Bioactive Lipids (Nicolaou A and Kokotos G eds) pp 107-134, Oily Press, Bridgwater, UK.
10.1016/S0361-9230(99)00027-1
Farooqui AA, Ong WY, and Horrocks LA (2003a) Plasmalogens, docosahexaenoic acid, and neurological disorders, in Peroxisomal Disorders and Regulation of Genes (Roels F, Baes M, and de Bies S eds) pp 335-354, Kluwer Academic/Plenum Publishers, London.
Farooqui AA, Ong WY, and Horrocks LA (2003b) Stimulation of lipases and phospholipases in Alzheimer disease, in Nutrition and Biochemistry of Phospholipids (Szuhaj B and van Nieuwenhuyzen W eds) pp 14-29, AOCS Press, Champaign, IL.
2000, Neuroscientist, 6, 169, 10.1177/107385840000600308
10.1016/S0169-328X(01)00214-5
Farooqui AA, Pendley CE II, Taylor WA, and Horrocks LA (1985) Studies on diacylglycerol lipases and lysophospholipases of bovine brain, in Phospholipids in the Nervous System, Vol. II: Physiological Role (Horrocks LA, Kanfer JN, and Porcellati G eds) pp 179-192, Raven Press, New York.
Farooqui AA, Rosenberger TA, and Horrocks LA (1997b) Arachidonic acid, neurotrauma, and neurodegenerative diseases, in Handbook of Essential Fatty Acid Biology (Yehuda S and Mostofsky DI eds) pp 277-295, Humana Press, Totowa, NJ.
10.1016/0021-9673(94)85033-X
10.1016/0165-0173(95)00008-9
10.1016/S0197-0186(96)00122-2
1997, J Neurochem, 69, 889, 10.1046/j.1471-4159.1997.69030889.x
1993, J Neurosci, 13, 1879, 10.1523/JNEUROSCI.13-05-01879.1993
10.1080/1071576042000209835
1994, Dev Brain Res, 78, 81, 10.1016/0165-3806(94)90012-4
10.1126/science.299.5604.191
1994, J Biol Chem, 269, 21639, 10.1016/S0021-9258(17)31853-7
10.1016/S0306-4522(99)00107-4
10.1016/0006-3223(94)00123-K
10.1007/s00702-004-0142-y
10.1016/0306-4522(92)90379-G
1991, N Engl J Med, 324, 1829, 10.1056/NEJM199106273242601
10.1016/j.biopsych.2004.05.012
2001, Biochim Biophys Acta, 1513, 160, 10.1016/S0005-2736(01)00349-2
1998, J Neurochem, 70, 2533, 10.1046/j.1471-4159.1998.70062533.x
10.1097/00005072-199907000-00008
1996, J Neurophysiol, 75, 1264, 10.1152/jn.1996.75.3.1264
10.1046/j.1471-4159.2001.00332.x
10.1016/S0090-6980(02)00022-9
10.1046/j.1471-4159.2002.00905.x
1993, J Biol Chem, 268, 9892, 10.1016/S0021-9258(18)98429-2
10.1016/S0166-2236(00)01563-0
2000, Biochim Biophys Acta, 1488, 124, 10.1016/S1388-1981(00)00115-3
10.1111/j.1471-4159.1992.tb09426.x
Horrobin DF (2003) Eicosapentaenoic acid derivatives in the management of schizophrenia, in Phospholipid Spectrum Disorders in Psychiatry and Neurology (Peet M, Glen L, and Horrobin DF eds) pp 371-376, Marius Press, Carnforth, Lancashire, UK.
1985, Cent Nerv Syst Trauma, 2, 115, 10.1089/cns.1985.2.115
10.1016/j.plefa.2003.12.011
10.1046/j.1471-4159.1999.0721133.x
10.1016/S0304-3940(98)00147-5
10.1016/0920-9964(96)00031-X
10.1046/j.1471-4159.2003.01848.x
2000, Am J Clin Nutr, 71, 343S, 10.1093/ajcn/71.1.343s
1995, NeuroReport, 7, 333
10.1016/0304-3940(92)90785-6
10.1097/00041444-200409000-00007
1995, News Physiol Sci, 10, 171
10.1016/S0896-6273(04)00003-0
10.1016/S0304-3940(98)00806-4
10.1016/0301-0082(95)00016-O
10.1016/S0306-4522(99)00051-2
1998, J Neurochem, 71, 2634, 10.1046/j.1471-4159.1998.71062634.x
2003, Rinsho Shinkeigaku, 43, 403
10.1097/00001756-200210280-00026
10.1111/j.1460-9568.2004.03111.x
10.1046/j.1471-4159.2003.01921.x
2004, Biochim Biophys Acta, 1636, 129, 10.1016/j.bbalip.2003.10.012
10.1016/S0006-3223(99)00067-0
2003, Eur J Biochem, 270, 36, 10.1046/j.1432-1033.2003.03356.x
10.1111/j.1471-4159.1990.tb05771.x
1996, Arch Pharm (Weinheim), 329, 483, 10.1002/ardp.19963291103
10.1016/S0223-5234(99)80066-X
10.1016/S0896-6273(00)80407-9
10.1111/j.1471-4159.2004.02540.x
10.1111/j.1471-4159.2004.02689.x
10.1016/S0140-6736(01)05748-8
10.1016/S0891-5849(01)00528-7
1996, Neurochem Res, 21, 869, 10.1007/BF02532334
10.1023/B:NERE.0000013750.80925.25
10.1046/j.1365-2990.1998.00121.x
10.1016/S0304-3940(98)00838-6
1983, J Neurochem, 41, 1576, 10.1111/j.1471-4159.1983.tb00867.x
10.1016/0922-4106(93)90040-G
10.1615/CritRevImmunol.v17.i3-4.10
Murphy EJ and Horrocks LA (1993) CDPcholine, CDPethanolamine, lipid metabolism and disorders of the central nervous system, in Phospholipids and Signal Transmission (Massarelli R, Horrocks L, Kanfer JN, and Löffelholz K eds) pp 353-372, Springer-Verlag GmbH, Heidelberg.
10.1016/S0304-3959(00)00468-1
10.1034/j.1600-0404.2000.102003143.x
10.1016/S1570-0232(03)00311-8
10.1016/S0306-4522(96)00608-2
10.1016/S0014-4886(03)00174-2
2003, Exp Brain Res, 148, 521, 10.1007/s00221-002-1315-2
10.1046/j.1471-4159.1999.721574.x
10.1042/0264-6021:3630727
10.1034/j.1600-079X.2001.310109.x
10.1016/j.freeradbiomed.2003.10.026
10.1016/S0169-328X(03)00262-6
Peet M and Ryles S (2001) Eicosapentaenoic acid—a potential new treatment for schizophrenia?, in Fatty Acids: Physiological and Behavioral Functions (Mostofsky DI, Yehuda S, and Salem N eds) pp 345-356, Humana Press Inc, Totowa, NJ.
1992, J Biol Chem, 267, 15578, 10.1016/S0021-9258(19)49575-6
1989, Ann NY Acad Sci, 568, 5, 10.1111/j.1749-6632.1989.tb12486.x
10.1016/0197-4580(95)02017-9
10.1097/00001756-199903170-00012
10.1016/j.brainresrev.2003.10.002
10.1056/NEJM200105173442006
10.1016/S1385-299X(03)00057-6
2003, Neuropsychopharmacology, 28, 1219
10.1016/S0006-8993(00)03280-7
1994, J Biochem, 269, 15619
10.1097/00001756-199912160-00030
1991, J Neurosci, 11, 1829, 10.1523/JNEUROSCI.11-06-01829.1991
10.1016/j.jneuroim.2004.01.005
10.1194/jlr.M200298-JLR200
10.1046/j.1471-4159.2003.02246.x
Ross BM (2003) Phospholipase A2-associated processes in the human brain and their role in neuropathology and psychopathology, in Phospholipid Spectrum Disorders in Psychiatry and Neurology (Peet M, Glen L, and Horrobin DF eds) pp 163-182, Marius Press, Carnforth, Lancashire, UK.
10.1001/archpsyc.1997.01830170113015
1995, J Neurochem, 64, 2213, 10.1046/j.1471-4159.1995.64052213.x
10.1016/S0006-8993(99)01123-3
10.1016/S0197-0186(03)00172-4
10.1016/S0006-8993(97)01552-7
10.1056/NEJM199704243361704
10.1097/00019052-199608000-00003
2004, Biochim Biophys Acta, 1684, 29, 10.1016/j.bbalip.2004.05.003
10.1016/j.prostaglandins.2004.03.005
2003, Mol Brain Res, 110, 85, 10.1016/S0169-328X(02)00642-3
10.1016/j.neuro.2003.08.008
10.1111/j.1440-1681.2004.03990.x
10.1023/B:NEUR.0000044191.83858.f7
10.1111/j.1471-4159.1989.tb08550.x
1987, J Neurochem, 49, 1, 10.1111/j.1471-4159.1987.tb03384.x
10.1016/0006-8993(96)00134-5
10.1002/(SICI)1098-1136(199908)27:2<110::AID-GLIA2>3.0.CO;2-C
2004, J Lipid Res, 45, 205, 10.1194/jlr.R300016-JLR200
10.1016/0024-3205(94)00393-9
Tabuchi S, Uozumi N, Ishii S, Shimizu Y, Watanabe T, and Shimizu T (2003) Mice deficient in cytosolic phospholipase A2 are less susceptible to cerebral ischemia/reperfusion injury, in Brain Edema XII (Kuroiwa T, Baethmann A, Czernicki Z, Hoff JT, Ito U, Katayama Y, Mararou A, Mendelow AD, and Reulen HJ eds) pp 169-172, Springer-Verlag Wien, Vienna.
1999, Lab Invest, 79, 609
10.1016/S0361-9230(00)00427-5
Taylor WA (1988) Effects of Impact Injury of Rat Spinal Cord on Activities of Some Enzymes of Lipid Hydrolysis. Doctoral Dissertation, The Ohio State University, Columbus, OH.
2003, Exp Brain Res, 150, 427, 10.1007/s00221-003-1476-7
1999, J Mol Neurosci, 12, 89, 10.1007/BF02736923
10.1016/S0006-2952(02)01066-3
10.1016/S1044-7431(03)00241-0
10.1097/00001756-200309150-00017
10.1016/S0090-6980(02)00021-7
10.1016/j.neuron.2004.09.010
1994, Int Rev Neurobiol, 36, 325, 10.1016/S0074-7742(08)60307-4
10.1111/j.1471-4159.2004.02373.x
10.1016/j.brainresbull.2004.04.005
1982, J Neurosurg, 56, 695, 10.3171/jns.1982.56.5.0695
10.1016/S0306-4522(03)00525-6
10.1016/0014-5793(95)01371-7
1994, J Biol Chem, 269, 3117, 10.1016/S0021-9258(17)42056-4
10.1016/S0891-5849(03)00152-7
10.1016/j.neuint.2003.12.006
10.1046/j.1471-4159.1999.0731278.x
Yao JK and Van Kammen DP (2004) Membrane phospholipids and cytokine interaction in schizophrenia, in Disorders of Synaptic Plasticity and Schizophrenia (Smythies J ed) pp 297-326, Academic Press, San Diego, CA.
10.1016/S0920-9964(99)00095-X
10.1034/j.1600-0404.2002.01238.x
10.1016/j.pain.2004.08.009
10.1016/0006-291X(90)92117-I
10.1016/S0006-291X(05)80992-1
10.1016/S0006-8993(99)02340-9
10.1016/S0304-3940(98)00262-6
10.1016/j.neuroscience.2004.03.057
10.1080/07315724.2004.10719345
